Journal
CLINICAL NUCLEAR MEDICINE
Volume 39, Issue 10, Pages E413-E426Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000000547
Keywords
FDG brain PET; amyloid brain PET; dementia; Alzheimer's disease
Funding
- Eli Lilly
Ask authors/readers for more resources
Objectives: The aim of this article was to review the current role of brain PET in the diagnosis of Alzheimer dementia. The characteristic patterns of glucose metabolism on brain FDG-PET can help in differentiating Alzheimer's disease from other causes of dementia such as frontotemporal dementia and dementia of Lewy body. Amyloid brain PET may exclude significant amyloid deposition and thus Alzheimer's disease in appropriate clinical setting. Conclusions: FDG-PET and amyloid PET imaging are valuable in the assessment of patients with Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available